title: Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model.
abstract: A new standard for medicine is emerging that aims to improve individual drug responses through studying associations with genetic variations. This field, pharmacogenomics, is undergoing a rapid expansion due to a variety of technological advancements that are enabling higher throughput with reductions in cost. Here we review the advantages, limitations, and opportunities for using lymphoblastoid cell lines (LCL) as a model system for human pharmacogenomic studies. There are a wide range of publicly available resources with genome-wide data available for LCLs from both related and unrelated populations, removing the cost of genotyping the data for drug response studies. Furthermore, in contrast to human clinical trials or in vivo model systems, with high-throughput in vitro screening technologies, pharmacogenomics studies can easily be scaled to accommodate large sample sizes. An important component to leveraging genome-wide data in LCL models is association mapping. Several methods are discussed herein, and include multivariate concentration response modeling, issues with multiple testing, and successful examples of the 'triangle model' to identify candidate variants. Once candidate gene variants have been determined, their biological roles can be elucidated using pathway analyses and functionally confirmed using siRNA knockdown experiments. The wealth of genomics data being produced using related and unrelated populations is creating many exciting opportunities leading to new insights into the genetic contribution and heritability of drug response.
authors.forename: J
authors.initials: J
authors.lastname: Jack
authors.forename: D
authors.initials: D
authors.lastname: Rotroff
authors.affiliation: Bioinformatics Research Center, 1 Lampe Drive, CB 7566, Ricks Hall, Raleigh, NC 27695, USA. motsinger@stat.ncsu.edu.
authors.forename: A
authors.initials: A
authors.lastname: Motsinger-Reif
mesh_terms: D002461:Cell Line, Transformed; D003362:Cost-Benefit Analysis; D055106:Genome-Wide Association Study / Q000191:economics / Q000379:methods*; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D008954:Models, Biological; D008957:Models, Genetic; D010597:Pharmacogenetics / Q000191:economics / Q000379:methods*; D020641:Polymorphism, Single Nucleotide; D034622:RNA Interference; D015203:Reproducibility of Results; D057170:Translational Research, Biomedical / Q000191:economics / Q000379:methods
references.citation: Mol Cancer Ther. 2008 Sep;7(9):3038-46
references.pmid: 18765826
references.citation: Blood. 2009 Mar 5;113(10):2145-53
references.pmid: 19109566
references.citation: Cancer Res. 2008 May 1;68(9):3161-8
references.pmid: 18451141
references.citation: Genomics. 1990 Mar;6(3):575-7
references.pmid: 2184120
references.citation: Hum Mol Genet. 2008 Oct 15;17(R2):R143-50
references.pmid: 18852203
references.citation: Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1485-92
references.pmid: 20413733
references.citation: Ann Oncol. 2003 Mar;14(3):449-54
references.pmid: 12598352
references.citation: Nat Commun. 2013;4:2126
references.pmid: 23839242
references.citation: Hum Genomics. 2009 Jan;3(2):128-42
references.pmid: 19164090
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9758-63
references.pmid: 17537913
references.citation: Nature. 2008 Oct 23;455(7216):1061-8
references.pmid: 18772890
references.citation: Am J Hum Genet. 2007 Sep;81(3):427-37
references.pmid: 17701890
references.citation: Pharmacogenomics J. 2013 Feb;13(1):35-43
references.pmid: 21844884
references.citation: Nature. 2009 May 28;459(7246):587-91
references.pmid: 19349959
references.citation: Cancer Res. 2008 Sep 1;68(17):7050-8
references.pmid: 18757419
references.citation: Nature. 2010 Oct 28;467(7319):1061-73
references.pmid: 20981092
references.citation: PLoS Genet. 2006 Aug;2(8):e123
references.pmid: 16895437
references.citation: J Pharmacogenomics Pharmacoproteomics. 2014 Mar 1;5(1):1000121
references.pmid: 25110614
references.citation: Proc Am Stat Assoc. 2011 Jul-Aug;2011:306-318
references.pmid: 30627054
references.citation: Genome Res. 2003 Sep;13(9):2092-100
references.pmid: 12915489
references.citation: Clin Pharmacol Ther. 2012 Oct;92(4):425-7
references.pmid: 22910437
references.citation: Pharmacogenomics. 2011 Feb;12(2):171-84
references.pmid: 21332311
references.citation: Am J Cardiol. 2006 Mar 15;97(6):843-50
references.pmid: 16516587
references.citation: Front Genet. 2011 Dec 14;2:86
references.pmid: 22303380
references.citation: Int J Biochem Cell Biol. 2010 Aug;42(8):1243-51
references.pmid: 19442757
references.citation: Nucleic Acids Res. 2002 Jan 1;30(1):163-5
references.pmid: 11752281
references.citation: Pharmacogenomics. 2011 Oct;12(10):1407-15
references.pmid: 22008047
references.citation: Pharmacogenomics. 2012 Jan;13(1):55-70
references.pmid: 22176622
references.citation: Pharmacogenet Genomics. 2010 May;20(5):327-37
references.pmid: 20393316
references.citation: Proc Biol Sci. 2011 Apr 22;278(1709):1183-8
references.pmid: 20926441
references.citation: Pharmacogenomics. 2014 Feb;15(2):137-46
references.pmid: 24444404
references.citation: PLoS One. 2009 Nov 09;4(11):e7765
references.pmid: 19898621
references.citation: Heart Rhythm. 2007 Jun;4(6):743-9
references.pmid: 17556195
references.citation: BioData Min. 2012 Dec 12;5(1):21
references.pmid: 23234571
references.citation: PLoS Genet. 2008 Nov;4(11):e1000287
references.pmid: 19043577
references.citation: Hum Hered. 2003;56(1-3):73-82
references.pmid: 14614241
references.citation: Nature. 2009 Oct 8;461(7265):747-53
references.pmid: 19812666
references.citation: Neuroreport. 2004 Jun 28;15(9):1443-6
references.pmid: 15194870
references.citation: PLoS One. 2011 May 05;6(5):e17561
references.pmid: 21573211
references.citation: Pharmacol Rev. 2009 Dec;61(4):413-29
references.pmid: 20038569
references.citation: Nature. 2003 Dec 18;426(6968):789-96
references.pmid: 14685227
references.citation: PLoS Genet. 2010 Apr 01;6(4):e1000888
references.pmid: 20369019
references.citation: BioData Min. 2014 Jun 14;7:9
references.pmid: 24976866
references.citation: Pharmacogenet Genomics. 2012 Nov;22(11):796-802
references.pmid: 23047291
references.citation: Circulation. 2008 Jul 1;118(1):96-101
references.pmid: 18591452
references.citation: Genet Epidemiol. 2008 Sep;32(6):567-73
references.pmid: 18425821